Background Comorbidity is highly prevalent between substance use disorders (SUDs) and
schizophrenia. This systematic review and meta-analysis estimated prevalence rates of …

Recent studies have begun to look at gender differences in schizophrenia and first‐episode
psychosis in an attempt to explain the heterogeneity of the illness. However, a number of …

Objective: To establish the extent to which use of cannabis, alcohol, and other psychoactive
substances affects the age at onset of psychosis by meta-analysis. Data Sources: Peer …

Artificial intelligence-based technologies are gradually being applied to psych-iatric
research and practice. This paper reviews the primary literature concerning artificial …

Although we have studied schizophrenia as a major disease entity over the past century, its
causes and pathogenesis remain obscure. In this article, we critically review genetic and …

Is depression simply the result of chemical imbalances, or Schizophrenia a wholly biological
disorder? What role do the broader circumstances of an individual's social, cultural and …

Patients with schizophrenia often fail to respond to an initial course of therapy. This study
systematically reviewed the societal and economic burden of treatment-resistant …

These guidelines from the British Association for Psychopharmacology address the scope
and targets of pharmacological treatment for schizophrenia. A consensus meeting, involving …

By describing patterns of disease distribution within populations, identifying risk factors, and
finding associations, epidemiologic studies have contributed to the current understanding of …

BackgroundRecent work suggests that heavy use of cannabis is associated with an
increased risk of schizophrenia-like psychosis. However, there is a dearth of experimental …